22 Mar 2011
Clariant International Ltd Press Kit Medtec 2011
Clariant Masterbatches presents the latest in its MEVOPUR® color masterbatches and custom performance compounds designed to bring cutting-edge functionality and aesthetics to medical devices and pharmaceutical packaging at Medtec 2011.
Press Releases
Clariant Masterbatches appoints regulatory and ISO 13485 expert to Medical and Pharmaceutical team
Muttenz, 22 March 2011 – Clariant Masterbatches reaffirms its commitment to the unique needs of its medical device and pharmaceutical packaging customers with the appointment of a dedicated global regulatory and ISO 13485 manager to its new Medical and Pharmaceutical segment.
Clariant Masterbatches Establishes Dedicated Medical and Pharmaceutical Global Segment
Muttenz, 23 February 2011 – Clariant has established a global Medical and Pharmaceutical segment within its Masterbatches Business Unit to further strengthen its dedicated support for customers in these highly-demanding markets.
Users of Advanced Medical Polymers Gain Controlled, Consistent, Compliant Color With New Clariant MEVOPUR® Masterbatches
Muttenz, 9 March 2011 – Manufacturers of medical devices and packaging who choose newer plastic materials like Eastman Tritan™ co-polyester and TOPAS® cyclic olefin copolymer (COC) now have readily available color options that are pretested and compliant with key standards governing materials used in medical and pharmaceutical applications. Available under the new Clariant Masterbatches brand name MEVOPUR®, these color concentrates and pre-color compounds are produced under specially controlled conditions in ISO13485 certified plants, using raw materials that have been biologically evaluated against USP parts 87 and 88 (Class VI devices) and/or the international standard ISO10993, and spectroscopically analyzed on delivery.
Bringing Distinctive Style to Medical Devices While Ensuring Safety, Regulatory Compliance
In today’s competitive marketplace manufacturers must try to differentiate their product from others by improving functionality and design. Use of drug delivery devices increasingly occurs outside of a hospital setting and since it is the patient rather than a doctor who is the user, the device must be attractive as well as convenient and functional. They become more like any other consumer product. That’s why color and other visual elements are increasingly important in device design.
Reader enquiries
Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland
Notes for editors
Clariant is an internationally active specialty chemical company based in Muttenz near Basel. The group owns over 100 companies worldwide and employed approx. 16.200 workers at the end of February 2011. In the financial year 2010, Clariant produced a turnover in excess of 7.1 billion CHF. Clariant is divided into ten business units: Additives; Detergents & Intermediates; Emulsions; Industrial & Consumer Specialties; Leather Services; Masterbatches; Oil & Mining Services; Paper Specialties; Pigments; Textile Chemicals.
Editorial enquiries
Stefanie Nehlsen
Clariant International Ltd
stefanie.nehlsen@clariant.com
Paulien Boumans
EMG